Another evidence revealed miR‐23a‐3p acted as tumour suppressor, its low expression predicted poor clinical outcome, and miR‐23a‐3p overexpression significantly inhibited the proliferation, invasion and tumorigenicity by targeting adenylate cyclase 1 (ADCY1).42 This evidence concerns the gene ADCY1 and neoplasm.